Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Cara Therapeutics
Cara Therapeutics
(CARA)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Korsuva
Difelikefalin
2021-08-23
2027
Pruritus
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Difelikefalin
healthy volunteers/patients
,
renal dialysis
,
chronic kidney failure
,
hip osteoarthritis
,
osteoarthritis
,
acute pain
,
knee osteoarthritis
,
arthritis
,
rheumatic diseases
,
joint diseases
,
musculoskeletal diseases
,
collagen diseases
,
biliary liver cirrhosis
,
cholangitis
,
postoperative pain
,
pruritus
,
kidney diseases
,
chronic renal insufficiency
,
back pain
,
atopic dermatitis
,
eczema
,
dermatitis
Corticoids
atopic dermatitis
,
eczema
,
pruritus
,
dermatitis
Triapine
pruritus
Trinessa
healthy volunteers/patients
Bolus
healthy volunteers/patients
,
renal dialysis
,
chronic kidney failure
,
kidney diseases
,
acute pain
Mydfrin
healthy volunteers/patients
Sominex
pruritus
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use